Purpose: The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD hPL) solution in patients with dry eye disease (DED) secondary to graft-versus-host disease (GvHD) after 6 weeks of treatment.
Design: A phase I/II, pilot, prospective, multicenter, randomized, double-masked clinical trial.
Participants: Patients with DED secondary to GvHD.
Purpose: To assess the effect of preoperative topical nonsteroidal antiinflammatory drugs (NSAIDs) on postoperative pain after laser-assisted subepithelial keratectomy (LASEK) and to investigate their mechanism.
Setting: Severance Eye Hospital and Saeyan Eye Clinic, Seoul, South Korea.
Design: Prospective randomized clinical trial.